Cullum RL, Lucas LM, Senfeld JI, Piazza JT, et al. Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics. PLoS One 2020;15:e0243901.
PMID: 33378376